St Vincent's Private Hospital Melbourne is a hospital group in Victoria of Australia that is located across four campuses in the Melbourne suburbs of Fitzroy, East Melbourne, Kew and Werribee, Victoria. Each campus is designated St Vincent's Private Hospital, and the suburb.

There are 480 beds in St Vincent's Hospital Melbourne.

During the past decade, St Vincent's Hospital Melbourne conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St Vincent's Hospital Melbourne" are "B-cell Lymphoid Malignancies" (1 trials), "Mature B-Cell Malignancies" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "St Vincent's Hospital Melbourne" in a lesser frequency.

Most popular intervention types in "St Vincent's Hospital Melbourne" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Zanubrutinib" (2 trials), "BGB-11417" (1 trials), "Docetaxel" (1 trials), "Obinutuzumab" (1 trials) and "Sitravatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Vincent's Hospital Melbourne" are 3 trials for "All" genders.

Currently, there are NaN active trials in "St Vincent's Hospital Melbourne". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in St Vincent's Hospital Melbourne, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St Vincent's Hospital Melbourne, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".